This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Institut Curie, Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2014.
Company Filing History:
2 out of 5,383 
2 out of 161 
1 out of 8,807 
Years Active: 2014
Title: Chi-Hung N'Guyen: Innovator in Isoquinolone Research
Introduction
Chi-Hung N'Guyen is a notable inventor based in Antony, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of isoquinolone derivatives. With a total of 2 patents, his work focuses on innovative methods for synthesizing compounds that have potential therapeutic applications.
Latest Patents
N'Guyen's latest patents include groundbreaking research on the use of isoquinolones for preparing drugs. This patent details novel isoquinolones and their synthesis methods, specifically targeting pathological angiogenesis and cancer treatment. Another significant patent involves condensed pyridine derivatives, which serve as potent inhibitors of the protein kinase CK2. This invention outlines the use of specific compounds for the preparation of pharmaceutical compositions aimed at treating various disorders, including cancers and autoimmune diseases.
Career Highlights
Throughout his career, Chi-Hung N'Guyen has worked with prestigious institutions such as the Centre National de la Recherche Scientifique and Institut Curie. His research has contributed to advancements in drug development and therapeutic strategies.
Collaborations
N'Guyen has collaborated with various professionals in his field, including his coworker Aurélie Juhem. Their joint efforts have furthered the understanding and application of isoquinolone derivatives in medicine.
Conclusion
Chi-Hung N'Guyen's innovative work in isoquinolone research highlights his commitment to advancing pharmaceutical science. His patents reflect a dedication to developing effective treatments for serious health conditions.